Literature DB >> 2132409

Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.

D Casiglia1, E Giardina, G Scarantino, G Triolo.   

Abstract

C3 fixing IgA immune complexes were found to be elevated in 25% of patients with type 2 (non insulin-dependent) diabetes mellitus as compared to healthy subjects (2%). Immune complexes containing both IgA and IgG were found in 42% of the diabetic population but not in controls. The presence of C3-IgA and/or IgA/IgG immune complexes correlated with the occurrence of antiglobulins antibodies of IgA class in particular with autoantibodies reactive with the Fab2 portion of IgG. These immunopathological findings were more frequent in patients that exhibited microvascular complications and in particular in patients with proliferative retinopathy. These and our previous results strongly suggest a role of IgA system abnormality in the pathogenesis of diabetic vascular complications.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2132409

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  3 in total

1.  Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications.

Authors:  E Ahmed; S Nityanand; A Mustafa; K Brismar; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus.

Authors:  P Gargiulo; J Goldberg; B Romani; R Schiaffini; P Ciampalini; W P Faulk; J A McIntyre
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

3.  Measurement of IgG levels can serve as a biomarker in newly diagnosed diabetic children.

Authors:  Medhat Haroun; Mohamed M El-Sayed
Journal:  J Clin Biochem Nutr       Date:  2007-01       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.